All maps are influenced by the intent and biases of their creator—even those that are striving to be as accurate as possible.

In honor of the beginning of America’s war against monarchical power, the event was a “No Monarchs in America” protest, ...

Sea turtles stranded on Cape Cod and Long Island this winter just got a second chance. Here's how rescuers helped them get ...

Thousands of people came to Lexington, Massachusetts, just before dawn on Saturday to witness a reenactment of how the American Revolution began 250 years ago, with the blast of gunshot and a trail of ...

The New England Patriots are scheduled to make nine of the draft's 257 picks, beginning with the No. 4 selection of the first round on Thursday night. NFL draft coverage: Latest expert mock drafts ...

The New England Patriots took themselves out of position to have a top-three pick in the 2025 NFL raft thanks to a Week 18 win over the Buffalo Bills. While it might cost them a shot at Travis ...

England pacer Jofra Archer has been on a roll over the past couple of games for Rajasthan Royals in the Indian Premier League (IPL) 2025. Archer produced a match-winning spell of 3/25 in 4 overs ...

The chart showed the number of new noncitizens who received Social Security numbers between fiscal 2021 and fiscal 2025 through a legal process known as "Enumeration Beyond Entry," or EBE.

Hyundai's "first-ever, three-row" electric vehicle is under production at the new Hyundai Motor Group Metaplant America (HMGMA) that celebrated its grand opening in Ellabell, Georgia, on Wednesday.

The New York Knicks host the Portland Trail Blazers on Sunday for their second and final 2024-25 NBA season encounter. During their previous meeting earlier this month, the Knicks defeated the ...

Five risk factors account for approximately 50% of the global burden of cardiovascular disease. How the presence or absence of classic risk factors affects lifetime estimates of cardiovascular ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...